Hello fellow developers and Apple Review Team,
I am reaching out to the community and any Apple App Review representatives here as a matter of absolute business urgency. Our essential health app, BeatO Diabetes Management (App ID: 1070739458), has been effectively paralyzed in the review queue for nearly 40 days (since late April 2026), severely impacting thousands of chronic care patients who rely on our ecosystem daily for blood glucose tracking.
We are completely aligned with Apple’s rigorous safety standards, but we have reached an operational dead end where detailed, compliant answers are met with week-long silence.
⏱️ The Timeline of the Review Deadlock:
Late April 2026: Initial build submitted. Flagged under Guideline 1.4.1 (Safety - Physical Harm) regarding our connection to external hardware (a CE-certified glucometer).
May 12, 2026: We provided absolute regulatory documentation: official CE certifications, supplier details, clinical validation reports, and proof of prominent American Diabetes Association (ADA) threshold disclaimers inside the UI.
May 15, 2026: Apple responded stating: "Your submission's review will require additional time... We do not require any further information at this time."
May 26/27, 2026: After a prolonged freeze, we halted the initial release to clear the pipe and submitted a completely fresh build (Submission ID: a0bf3856-693b-4577-adc7-9199a5f9fe34) hoping to reset any stuck internal states.
May 27, 2026: Apple requested information under Guideline 2.1 (Information Needed) asking two specific questions about algorithmic personalization and our "tailored diabetes program" marketing text.
May 27, 2026: Within a couple of hours, we provided an exhaustive, definitive response:
Clarified ADA Guidelines: Confirmed that high/low glucose classifications are strictly based on standard published clinical data (ADA Standards of Care) and explicitly disclosed in our Terms & Conditions, not personalized by an algorithm.
Clarified Program Architecture: Proved that 0% of the program is generated by an algorithm. The app acts purely as an introductory storefront/brochure. The actual care management is fulfilled entirely offline directly by human doctors and certified medical professionals. It is definitively not an algorithmic medical device feature.
May 28, 2026 to Present: The app was re-entered into the "In Review" state and has sat completely frozen ever since.
🛑 The Core Problem & Business Impact
We have successfully provided every piece of documentation Apple has asked for - legal, medical, clinical, and architecture definitions. The reviewer explicitly stated they have everything they need, yet we are trapped in an endless manual review loop.
Because our app manages active diabetic health metrics, this prolonged delay prevents us from deploying critical performance optimizations and bug fixes. Our patient support lines are flooding, and our operational product roadmap for the quarter is completely stalled.
🙏 Request to the Community / Apple Engineers
Has anyone else dealing with health hardware/software integration hit this specific wall where your answers are fully compliant, but the review desk simply stops processing the ticket?
If any Apple App Review moderators or App Store Connect engineers see this, we respectfully request an internal escalation or an App Review Appointment to unblock this build. We are ready to jump on a call immediately to provide any final clarity required.
App Name: BeatO Diabetes Management
App ID: 1070739458
Latest Submission ID: a0bf3856-693b-4577-adc7-9199a5f9fe34
Thank you for your time and guidance.
Regards,
Sanketkumar Biswas